Atrial Flutter Market to Register Stunning Growth During the Forecast Period (2019-32) – Estimates DelveInsight | Key Companies – Acutus Medical, ARCA Biopharma (Medtronic), Adagio Medical, and Others

July 07 12:54 2022
Atrial Flutter Market to Register Stunning Growth During the Forecast Period (2019-32) - Estimates DelveInsight | Key Companies - Acutus Medical, ARCA Biopharma (Medtronic), Adagio Medical, and Others
Delveinsight Business Research LLP
DelveInsight’s “Atrial Flutter Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Atrial Flutter Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Atrial Flutter market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Atrial Flutter: An Overview

Atrial flutter is a kind of arrhythmia and it is a problem with the way the heart beats. Atrial flutter is called supraventricular (above the ventricles) tachycardia because it comes from the atria.

In atrial flutter, the heart’s upper chambers (atria) beat too quickly. This causes the heart to beat in a fast, but usually regular, rhythm. It beats extra fast, about 250-400 beats per minute. A normal heartbeat is 60-100 beats per minute.

Atrial Flutter Market Key Facts

  • According to Ziccardi et al. (2020), Atrial flutter is the second most common cardiac arrhythmia after atrial fibrillation. Atrial flutter is more frequent in males than in females. Older age is associated with an increased risk of atrial fibrillation and atrial flutter.

  • According to Global Health Data Exchange, nearly 8 out of 10 adults, suffering from (or diagnosed with) Atrial fibrillation or Atrial Flutter are 65 years old or older.

  • As per the secondary sources, more than Atrial fibrillation is the most common arrhythmia diagnosed in clinical practice. Estimates of the prevalence of AFib in the United States range from about 2.7 million to 6.1 million (Centers for Disease Control and Prevention (CDC)) and 30 to 50 percent of those also have atrial flutter (Baptist Health South Florida, 2021).

Atrial Flutter Market

As per DelveInsight, Atrial Flutter Market is anticipated to increase in the coming years owing to the increasing geriatric population and rising cases of Atrial flutter in the 7MM.

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Atrial Flutter market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Atrial Flutter market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.

Atrial Flutter Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.

Atrial Flutter Epidemiology Segmentation

  • Total incident cases of Atrial flutter segmented by age

  • Total incident Cases of Atrial flutter

  • Total treated cases of Atrial flutter

  • Total incident cases of Atrial flutter segmented by gender

Atrial Flutter Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Atrial Flutter market or expected to get launched during the study period. The analysis covers Atrial Flutter market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Atrial Flutter Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report –

Atrial Flutter Therapeutics Analysis

As per DelveInsight’s assessment, only a few companies are indulged in developing a novel treatment option for atrial flutter. This might be due to the difficulty in studying Atrial flutter, given its inherent heterogeneity and challenges related to the evaluation of ablation and device therapies in this space. 

Currently, ongoing studies are primarily focused on atrial fibrillation due to several reasons and one of them is the lack of scientific data about Atrial Flutter.

Some of the key companies in the Atrial Flutter Market include:

  • Acutus Medical

  • ARCA Biopharma (in collaboration with Medtronic)

  • Adagio Medical

And many others

Atrial Flutter Therapies covered in the report include:

  • AcQBlate Force Sensing Ablation System

  • Gencaro (bucindolol hydrochloride)

  • Intelligent Continuous Lesion Ablation System (iCLAS)

And may more

Get More Detailed Insights Into the Emerging Therapies & Key Companies –

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Atrial Flutter Competitive Intelligence Analysis

4. Atrial Flutter Market Overview at a Glance

5. Atrial Flutter Disease Background and Overview

6. Atrial Flutter Patient Journey

7. Atrial Flutter Epidemiology and Patient Population

8. Atrial Flutter Treatment Algorithm, Current Treatment, and Medical Practices

9. Atrial Flutter Unmet Needs

10. Key Endpoints of Atrial Flutter Treatment

11. Atrial Flutter Marketed Products

12. Atrial Flutter Emerging Therapies

13. Atrial Flutter Seven Major Market Analysis

14. Attribute Analysis

15. Atrial Flutter Market Outlook (7 major markets)

16. Atrial Flutter Access and Reimbursement Overview

17. KOL Views on the Atrial Flutter Market.

18. Atrial Flutter Market Drivers

19. Atrial Flutter Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report –

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.


Other Trending Healthcare Reports by DelveInsight

Cancer Vaccines Market
“Cancer Vaccines Market” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Cancer Vaccines Market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States